Washington, DC (October 29, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement regarding the recent report by the Food and Drug Administration (FDA) Drug Shortages Task Force on drug shortages:
“Ongoing critical prescription drug shortages jeopardize patient access to essential medications. As FDA has noted, the causes of drug shortages are complex and multifactorial, requiring an all-hands-on-deck, multi-stakeholder solution. HSCA and its member group purchasing organizations (GPOs) are on the front lines of helping providers prevent and mitigate drug shortages, working collaboratively with hospitals, physicians, manufacturers, distributors, and government agencies to ensure that providers and patients have access to the life-saving drugs they need.
Click here to read the full release.Lear More
Comments of the Healthcare Supply Chain Association (HSCA) on Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration’s (DEA or Agency) proposed aggregate production quotas for Schedule I and II controlled substances. HSCA supports DEA’s efforts to support interagency collaboration around controlling opioid diversion. We are concerned, however, that absent differentiation of injectable opioids from solid dosage form for purposes of the rule, these changes to aggregate production quotas could lead to injectable narcotic shortages that threaten patient care.
Click here for the full comments.Lear More
Washington, DC (September 23, 2019) – The Healthcare Supply Chain Association (HSCA), the association representing the nation’s leading healthcare group purchasing organizations (GPOs), today announced HSCA President and CEO Khatereh Calleja will moderate a panel on “Chasing Value: Understanding How to Work with GPOs to Introduce New Health Care Innovation in the Supply Chain” at AdvaMed’s MedTech Conference on Monday, September 23rd at the Boston Convention and Exhibition Center in Boston, Massachusetts.
The panel will feature healthcare leaders from Vizient, Premier, Intalere, 410 Medical, and Access Scientific. Panelists will discuss successful partnerships, best practices and how they have successfully worked together and launched new innovations.
Click here for the full release.